Looking at a possible molecular mechanism, we observed that BCL2 was not inhibited by DMF; rather, a trend toward an increase was observed in primary CLL cells, as previously reported in other cellular contexts [55]. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.